Showing 17,521 - 17,540 results of 17,760 for search '(( 50 ((n decrease) OR (nn decrease)) ) OR ( 59 ((a decrease) OR (mean decrease)) ))', query time: 0.87s Refine Results
  1. 17521

    Image_2_TGF-β phospho antibody array identifies altered SMAD2, PI3K/AKT/SMAD, and RAC signaling contribute to the pathogenesis of myxomatous mitral valve disease.TIF by Andrew J. McNair (9093310)

    Published 2023
    “…SMAD2 antagonism by siRNA and the SMAD7 agonist asiaticoside decreased detection of pSMAD by at least 50%, significantly decreased expression of the aVIC gene markers ACTA2, TAGLN, and MYH10, and pαSMA, pAKT2, and pERK1, but had no effect on pS6K, pERK2, or pVIM expression in aVICs. …”
  2. 17522
  3. 17523

    Table_1_TGF-β phospho antibody array identifies altered SMAD2, PI3K/AKT/SMAD, and RAC signaling contribute to the pathogenesis of myxomatous mitral valve disease.docx by Andrew J. McNair (9093310)

    Published 2023
    “…SMAD2 antagonism by siRNA and the SMAD7 agonist asiaticoside decreased detection of pSMAD by at least 50%, significantly decreased expression of the aVIC gene markers ACTA2, TAGLN, and MYH10, and pαSMA, pAKT2, and pERK1, but had no effect on pS6K, pERK2, or pVIM expression in aVICs. …”
  4. 17524

    Image_3_TGF-β phospho antibody array identifies altered SMAD2, PI3K/AKT/SMAD, and RAC signaling contribute to the pathogenesis of myxomatous mitral valve disease.TIF by Andrew J. McNair (9093310)

    Published 2023
    “…SMAD2 antagonism by siRNA and the SMAD7 agonist asiaticoside decreased detection of pSMAD by at least 50%, significantly decreased expression of the aVIC gene markers ACTA2, TAGLN, and MYH10, and pαSMA, pAKT2, and pERK1, but had no effect on pS6K, pERK2, or pVIM expression in aVICs. …”
  5. 17525

    Data_Sheet_2_TGF-β phospho antibody array identifies altered SMAD2, PI3K/AKT/SMAD, and RAC signaling contribute to the pathogenesis of myxomatous mitral valve disease.docx by Andrew J. McNair (9093310)

    Published 2023
    “…SMAD2 antagonism by siRNA and the SMAD7 agonist asiaticoside decreased detection of pSMAD by at least 50%, significantly decreased expression of the aVIC gene markers ACTA2, TAGLN, and MYH10, and pαSMA, pAKT2, and pERK1, but had no effect on pS6K, pERK2, or pVIM expression in aVICs. …”
  6. 17526

    Image_1_TGF-β phospho antibody array identifies altered SMAD2, PI3K/AKT/SMAD, and RAC signaling contribute to the pathogenesis of myxomatous mitral valve disease.TIF by Andrew J. McNair (9093310)

    Published 2023
    “…SMAD2 antagonism by siRNA and the SMAD7 agonist asiaticoside decreased detection of pSMAD by at least 50%, significantly decreased expression of the aVIC gene markers ACTA2, TAGLN, and MYH10, and pαSMA, pAKT2, and pERK1, but had no effect on pS6K, pERK2, or pVIM expression in aVICs. …”
  7. 17527

    Data_Sheet_1_TGF-β phospho antibody array identifies altered SMAD2, PI3K/AKT/SMAD, and RAC signaling contribute to the pathogenesis of myxomatous mitral valve disease.docx by Andrew J. McNair (9093310)

    Published 2023
    “…SMAD2 antagonism by siRNA and the SMAD7 agonist asiaticoside decreased detection of pSMAD by at least 50%, significantly decreased expression of the aVIC gene markers ACTA2, TAGLN, and MYH10, and pαSMA, pAKT2, and pERK1, but had no effect on pS6K, pERK2, or pVIM expression in aVICs. …”
  8. 17528
  9. 17529

    DataSheet_1_Does Routine Anti-Osteoporosis Medication Lower the Risk of Fractures in Male Subjects? An Updated Systematic Review With Meta-Analysis of Clinical Trials.doc by Ling-Feng Zeng (7172462)

    Published 2019
    “…</p><p>Conclusions: This systematic review confirms that bisphosphonates were connected with a decreased risk of vertebral fractures, nonvertebral fractures, and clinical fractures for male subjects with osteoporosis. …”
  10. 17530

    Video_1_Reverse-sequence endoscopic nipple-sparing mastectomy with immediate implant-based breast reconstruction: an improvement of conventional minimal access breast surgery.mov by Kawun Chung (18111136)

    Published 2024
    “…Patients in the R-E-NSM group had significantly shorter operation time (204.6 ± 59.2 vs. 318.9 ± 75.5 minutes, p<0.001) and anesthesia time (279.4 ± 83.9 vs. 408.9 ± 87.4 minutes, p<0.001) and decreased medical costs [5063.4 (4439.6-6532.3) vs. 6404.2 (5152.5-7981.5), USD, p=0.001] and increase SCAR-Q scores (77.2 ± 17.1 vs. 68.8 ± 8.7, P=0.002) compared to the C-E-NSM group. …”
  11. 17531

    Supplementary file 1_Ultrafine garlic powder alleviates non-alcoholic steatohepatitis by inhibiting hepatocyte ferroptosis and modulating ERK-dependent oxidative stress.docx by Junhui Yu (8899847)

    Published 2025
    “…</p>Results<p>UGP exhibited a particle size (d(0.5) of approximately 4 μm) that is 30 times smaller than TGP, showing significantly smaller particle size and lower contact angle (UGP=59.775°vs TGP=83.545°). …”
  12. 17532

    Image1_Training at moderate altitude improves submaximal but not maximal performance-related parameters in elite rowers.pdf by Hugo Cerda-Kohler (5755775)

    Published 2022
    “…LHTL training improves performance-related variables at sea level (V̇E<sub>max</sub>: 3.3% (95% CI, 1.2–5.5); hemoglobin concentration ([Hb]): 4.3% (95% CI, 1.7–6.9); hematocrit (%): 4.5% (95% CI, 0.9–8.2); RBC (red blood cells) count: 5.3% (95% CI, 2.3–8.2); power at VT2: 6.9% (95% CI, 1.7–12.1), V̇E<sub>VT2</sub>: 6.4% (95% CI, 0.4–12.4); power at VT1: 7.3% (95% CI, 1.3–13.3), V̇E<sub>VT1</sub>: 8.7% (95% CI, 1.6–15.8)) and economy/efficiency-related variables (ECR<sub>VT2</sub>: 5.3% (95% CI, −0.6 to −10.0); GE(%): 5.8% (95% CI, 0.8–10.7)). The LHTH training decreased breathing economy at MAP (−2.8% (95% CI, 0.1–5.6)), pVT2 (−9.3% (95% CI, −5.9 to −12.7)), and pVT1 (−9.3% (95% CI, −4.1 to −14.4)). …”
  13. 17533

    DataSheet_1_177Lu-labeled PSMA targeting therapeutic with optimized linker for treatment of disseminated prostate cancer; evaluation of biodistribution and dosimetry.docx by Ayman Abouzayed (17051256)

    Published 2023
    “…The binding of [<sup>177</sup>Lu]Lu-BQ7876 to living cells was characterized by rapid association, while the dissociation included a rapid and a slow phase with affinities K<sub>D1</sub> = 3.8 nM and K<sub>D2</sub> = 25 nM. …”
  14. 17534

    Fine Mapping and Candidate Gene Search of Quantitative Trait Loci for Growth and Obesity Using Mouse Intersubspecific Subcongenic Intercrosses and Exome Sequencing by Akira Ishikawa (267667)

    Published 2014
    “…We fine-mapped <i>Pbwg1.3</i> for body length to an 8.0-Mb interval (57.3–65.3) and <i>Pbwg1.5</i> for abdominal white fat weight to a 2.1-Mb interval (59.4–61.5). The wild-derived allele at <i>Pbwg1.12</i> and <i>Pbwg1.3</i> uniquely increased body weight and length despite the fact that the wild mouse has a smaller body size than that of B6, whereas it decreased fat weight at <i>Pbwg1.5</i>. …”
  15. 17535

    Interferon-free therapy with direct acting antivirals for HCV/HIV-1 co-infected Japanese patients with inherited bleeding disorders by Haruka Uemura (4521400)

    Published 2017
    “…</p><p>Results</p><p>Eighteen (67%) patients had had received interferon-based therapy, and 11 (41%) had compensated cirrhosis. HCV genotypes were GT1a 4 (15%), GT1b 16 (59%), GT1 undetermined 2 (7%), GT2a 1 (4%), GT3a 3 (11%) and GT4a 1 (4%). …”
  16. 17536

    RNA-seq transcriptomics analysis in human tissue culture cells reveals changes in the expression levels of over 100 nucleolar mRNAs after PAX9 knockdown. by Katherine I. Farley-Barnes (9258036)

    Published 2020
    “…Of these, 812 mRNAs had a decreased fold change (≤ -2) and 184 of those mRNAs code for proteins designated as nucleolar in at least one of three databases [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1008967#pgen.1008967.ref050" target="_blank">50</a>–<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1008967#pgen.1008967.ref052" target="_blank">52</a>]. …”
  17. 17537

    <i>Csp_P</i> exposure causes high mortality in adults and larvae. by Jose Luis Ramirez (179343)

    Published 2014
    “…In septic <i>Ae. aegypti</i>, survival was significantly decreased after feeding on a 10<sup>10</sup> CFU/ml sugar meal (D, p<0.0001) but not after feeding on a 10<sup>6</sup> CFU/ml sugar meal (D, p = 0.08). …”
  18. 17538

    Pharmacological blockade of K<sub>ATP</sub> channels negates the hippocampal synaptic and neuronal protection afforded by ketones. by Do Young Kim (131974)

    Published 2015
    “…Each vertical bar indicates the mean ± SEM (n = 30). (D) Representative photomicrographs of HT22 cells under control conditions, with H<sub>2</sub>O<sub>2</sub>, or when H<sub>2</sub>O<sub>2</sub> was co-treated with ACA at two time-points (0 and 24 hrs). …”
  19. 17539

    Genome-wide miRNA response to anacardic acid in breast cancer cells by David J. Schultz (4423906)

    Published 2017
    “…Anacardic acid (AnAc) is a dietary phenolic lipid that inhibits both MCF-7 estrogen receptor α (ERα) positive and MDA-MB-231 triple negative breast cancer (TNBC) cell proliferation with IC<sub>50</sub>s of 13.5 and 35 μM, respectively. To identify potential mediators of AnAc action in breast cancer, we profiled the genome-wide microRNA transcriptome (microRNAome) in these two cell lines altered by the AnAc 24:1n5 congener. …”
  20. 17540

    Influence of T180A-SHIP2 on LEC functional responses. by Germaine D. Agollah (623510)

    Published 2014
    “…Scale bar  = 100 µm (<b>B</b>) and 50 µm (<b>C</b> and <b>D</b>) MW =  molecular weight marker.…”